Earnings Call Archives - ChartAlert®

HINDALCO – Hindalco Industries – Q4 FY26 Earnings Call – 22-May-26

HINDALCO’s topline leveraged to aluminum/copper prices and premiums; bottomline sensitive to exceptional items (Oswego, TC/RCs) and cost inflation; margins hinge on operational efficiencies (Novelis cost cuts, captive coal) and regional premiums.

1–2 minutes

Also see: HINDALCO – Hindalco Industries – Q4 FY26 Financial Results – 22-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Aluminum market rebalances in H2 CY26 as European/West Asia restarts and Indonesia ramp-ups offset disruptions. LME averages $2,800–3,000/ton, Midwest premiums normalize to $300–350/ton, and sulfuric acid prices correct in H2 FY27. Bay Minette ramp-up proceeds as planned, captive coal contributes modestly in FY28, and cost inflation stabilizes at ~3–5%. Consolidated EBITDA grows 8–10% in FY27, with net debt-to-EBITDA ~1.9x.

GRASIM – Grasim Industries – Q4 FY26 Earnings Call – 20-May-26

GRASIM’s topline growth hinges on paints/B2B scale-up and macro stability; bottomline/margins depend on raw material cost pass-through and operating leverage in new businesses.

1–2 minutes

Also see: GRASIM – Grasim Industries – Q4 FY26 Financial Results – 20-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Global raw material prices stabilize by H2 FY27; price hikes stick (2–6% + Q1 FY27 increases). Paints market share gains continue (90bps+ QoQ), throughput improves with dealer maturation. B2B e-commerce hits EBITDA break-even by FY27 end. Revenue: INR 1,90,000–2,00,000 crore (FY27), EBITDA margins expand via scale and cost levers.

POWERGRID – Power Grid Corporation – Q4 FY26 Earnings Call – 18-May-26

Power Grid Corporation’s topline growth is structurally robust (₹15 lakh crore+ opportunity), but bottomline and margins hinge on execution pace (CapEx → capitalization conversion) and cost mitigation (RoW, supply chain, IRR protection).

1–2 minutes

Also see: POWERGRID – Power Grid Corporation – Q4 FY26 Financial Results – 15-May-26

3-Scenario Framework

📊 Base Case (60% Probability)

CapEx sustains at ₹40,000–45,000 crore/year (FY27–FY29) with ₹30,000–35,000 crore capitalization, driven by TBCB pipeline execution (₹1.1 lakh crore bidding) and HVDC rollouts (2–3/year). RoW and supply chain bottlenecks ease via market rate mechanisms and OEM expansions. PAT grows 8–10% CAGR (FY26–FY29) on capitalization tailwinds; margins stable (~25% EBITDA) as cost inflation offset by change-in-law claims. ESG leadership and global PPPs add 5–10% to valuation premium.

BOSCHLTD – Bosch Limited – Q4 FY26 Earnings Call – 21-May-26

Bosch’s findings imply topline resilience (8–10% base-case growth) with margin expansion (50bps) hinging on cost controls and content per vehicle, while PAT growth (10–12%) is anchored by structural initiatives but vulnerable to macro shocks.

1–2 minutes

Also see: BOSCHLTD – Bosch Limited – Q4 FY26 Financial Results – 20-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Macro stability persists; crude oil rises 10%, but supply chain agility offsets costs. Flattish volume growth is offset by content per vehicle gains (CAFE Phase 3, ADAS). JV ramps up in FY’28, contributing 2–3% to revenue. Revenue grows 8–10%, EBITDA margins expand 50bps, and PAT grows 10–12%.

ZYDUSLIFE – Zydus Lifesciences – Q4 FY26 Earnings Call – 19-May-26

Zydus Lifesciences’ topline growth hinges on specialty scaling and international momentum, while margins and cash flow are sensitive to US generics competition, acquisition execution, and capex intensity.

1–2 minutes

Also see: ZYDUSLIFE – Zydus Lifesciences – Q4 FY26 Financial Results – 19-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Management delivers on high-teens revenue growth and >24% EBITDA margins in FY27. US generics decline offset by specialty/international growth, while MedTech/Comfort Click meet guidance. Capex/working capital pressure limits FCF growth, but leverage remains <1x net debt-to-EBITDA. Biosimilar scale-up aligns with FY29–30 timeline.

APOLLOHOSP – Apollo Hospitals Enterprise – Q4 FY26 Earnings Call – 21-May-26

Findings imply APOLLOHOSP/ Apollo Hospitals’ resilient topline growth (10–15%) with margin stability (EBITDA ±20–50 bps) but high sensitivity to macroeconomic and regulatory risks.

1–2 minutes

Also see: APOLLOHOSP – Apollo Hospitals Enterprise – Q4 FY26 Financial Results – 20-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

FY27 delivers 12–15% volume growth and 20–25 bps margin expansion, supported by stable macroeconomic conditions and execution of capex plans. Free cash flow remains robust, funding dividends and debt reduction. Key variables: Inflation at 5–6%, no major regulatory shocks.

ITC – ITC Limited – Q4 FY26 Investor Presentation – 21-May-26

ITC’s topline resilience hinges on FMCG-Others and NewGen channels, while bottomline and margins face structural pressure from taxation, illicit trade, and input costs.

1–2 minutes

Also see: ITC – ITC Limited – Q4 FY26 Financial Results – 21-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Tax hikes partially offset by pricing, but illicit trade captures 5-10% volume. Agri remains subdued due to geopolitical risks, while FMCG-Others sustains 10% revenue growth. EBITDA grows 5-7% YoY, with margins stable but compressed in Cigarettes/Paperboards.

BEL – Bharat Electronics – Q4 FY26 Earnings Call – 20-May-26

BEL/ Bharat Electronics’ topline resilience hinges on order execution (QRSAM/P-75I); margins remain robust (>28%) if indigenization offsets cost inflation, but cash flow conversion and working capital are key watchpoints.

1–2 minutes

Also see: BEL – Bharat Electronics – Q4 FY26 Financial Results – 19-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

QRSAM signs by Jun-2026, but P-75I slips to FY28; order inflow at ~INR 50,000 cr. EBITDA margins sustain at 28–29% (wage/semiconductor offsets indigenization gains). Revenue grows 15–16%, with cash conversion improving to 25%. Non-defense/export contribute 10–12% of revenue.

AMBER – Amber Enterprises – Q4 FY26 Earnings Call – 18-May-26

AMBER/ Amber Enterprises’ topline growth remains robust (20%+ base case), but margin compression (50–100 bps) and working capital strain are near-term headwinds; long-term PCB leadership and Railway order book underpin structural upside.

1–2 minutes

Also see: AMBER – Amber Enterprises – Q4 FY26 Financial Results – 16-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Commodity inflation stabilizes (no further spikes), RDSO approvals on time, RAC industry grows 12–13%.
FY27 revenue grows ~20% (Electronics +40%, Railway +30%, Consumer Durables +12%). Margins compress 50–100 bps (partial pass-through). Net debt at INR 700–800 crores; capex cash outflow INR 1,100–1,200 crores. Ascent-K trial production Q3 FY28.

JSWSTEEL – JSW Steel – Q4 FY26 Earnings Call – 14-May-26

JSW Steel’s topline grows 10–14% CAGR (demand + capacity), bottomline leverages operating leverage + deleveraging, while margins remain resilient (18–22%) but sensitive to raw material costs and execution risks.

1–2 minutes

Also see: JSWSTEEL – JSW Steel – Q4 FY26 Financial Results – 14-May-26

3-Scenario Framework

📊 Base Case (60% Probability)

Key Variables: Domestic demand grows 7–9% (FY27), capex execution on track, coking coal costs stabilize at +$12–15/tonne.
Outcome: Revenue CAGR ~10%, EBITDA margins sustain at 18–20%, net debt/EBITDA <2.5x. 62M tonnes capacity by FY32 supports market share gains in flat steel. JV contributions (16M tonnes) accelerate growth without overleveraging.